Workflow
Revolution Medicines to Host RAS(ON) Inhibitor Clinical Update Webcast on December 2, 2024
RVMDRevolution Medicines(RVMD) GlobeNewswire News Room·2024-11-28 05:05

REDWOOD CITY, Calif., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that it will host an investor webcast to provide clinical updates from its RAS(ON) inhibitor portfolio. The webcast will take place at 8:00 a.m. Eastern Time on Monday, December 2, 2024. To access the webcast, click here. An archived replay will be available on the “Events & Presentations” p ...